Dose-dependent changes in the locomotor responses to methamphetamine in BALB/c mice: Low doses induce hypolocomotion
暂无分享,去创建一个
Thomas R. Kosten | T. Kosten | B. Kinsey | T. Kosten | F. Orson | Rana A.K. Singh | Therese A. Kosten | Berma M. Kinsey | Xiaoyun Shen | Angel Y. Lopez | Frank M. Orson | Xiaoyun Y Shen | Rana A. K. Singh
[1] S. Shoptaw,et al. Psychiatric and Substance Dependence Comorbidities, Sexually Transmitted Diseases, and Risk Behaviors Among Methamphetamine-Dependent Gay and Bisexual Men Seeking Outpatient Drug Abuse Treatment , 2003, Journal of psychoactive drugs.
[2] I. Grant,et al. Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence? , 2007, The American journal on addictions.
[3] F. George. Cocaine produces low dose locomotor depressant effects in NBR and F344 rats , 1990, Pharmacology Biochemistry and Behavior.
[4] R. Rawson,et al. Methamphetamine dependence and human immunodeficiency virus risk behavior. , 2008, Journal of substance abuse treatment.
[5] Rivière Gj,et al. SPONTANEOUS LOCOMOTOR ACTIVITY AND PHARMACOKINETICS OF INTRAVENOUS METHAMPHETAMINE AND ITS METABOLITE AMPHETAMINE IN THE RAT , 1999 .
[6] N. Mataga,et al. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. , 1983, European journal of pharmacology.
[7] K. Rice,et al. Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.
[8] Y. Yook,et al. PRECLINICAL STUDY: Proteomic analysis of methamphetamine‐induced reinforcement processes within the mesolimbic dopamine system , 2008, Addiction biology.
[9] S. M. Owens,et al. Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons , 2006, Psychopharmacology.
[10] A. Weinstein,et al. Pharmacological approaches to methamphetamine dependence: a focused review. , 2010, British journal of clinical pharmacology.
[11] G. Hanson,et al. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. , 2007, Addiction.
[12] T. Robbins,et al. A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats , 2004, Psychopharmacologia.
[13] J. Kebabian,et al. Multiple receptors for dopamine , 1979, Nature.
[14] S. M. Owens,et al. Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats. , 2005, European journal of pharmacology.
[15] D. Kavanagh,et al. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users. , 2009, Addictive behaviors.
[16] Jean Logan,et al. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study , 2002, Synapse.
[17] G. Hanson,et al. New insights into the mechanism of action of amphetamines. , 2007, Annual review of pharmacology and toxicology.
[18] P. H. Andersen,et al. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. , 1990, European journal of pharmacology.
[19] K. Kitahama,et al. Strain differences in amphetamine sensitivity in mice , 1979, Psychopharmacology.
[20] T. Macedo,et al. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase‐3 in caudate‐putamen , 2006, Synapse.
[21] D. Weinshenker,et al. Perspective There and Back Again : A Tale of Norepinephrine and Drug Addiction , 2007 .
[22] H. Loh,et al. μ‐Opioid receptor knockout mice are insensitive to methamphetamine‐induced behavioral sensitization , 2010, Journal of neuroscience research.
[23] J. Maxwell. Emerging research on methamphetamine , 2005, Current opinion in psychiatry.
[24] N. Volkow,et al. Drug addiction: the neurobiology of behaviour gone awry , 2004, Nature Reviews Neuroscience.
[25] T. Archer,et al. Effects of clonidine and α-adrenoceptor antagonists on motor activity in DSP4-treated mice I: Dose-, time- and parameter-dependency , 1999, Neurotoxicity Research.
[26] Leanne Hides,et al. The prevalence of psychotic symptoms among methamphetamine users. , 2006, Addiction.
[27] S. M. Owens,et al. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague–Dawley rats , 2007, Pharmacology Biochemistry and Behavior.
[28] S. Iversen,et al. The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat , 2004, Psychopharmacologia.
[29] S. Batki,et al. Stimulant psychosis: symptom profile and acute clinical course. , 2000, The American journal on addictions.
[30] T. Dawson,et al. Methamphetamine-induced reduction in D1 and D2 dopamine receptors as evidenced by autoradiography: Comparison with tyrosine hydroxylase activity , 1987, Neuroscience.
[31] W. Haning,et al. Electrocardiographic abnormalities in methamphetamine abusers. , 2007, Addiction.
[32] Rita Z. Goldstein,et al. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. , 2002, The American journal of psychiatry.
[33] M. Nomoto,et al. Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: comparison with apomorphine. , 1995, European journal of pharmacology.
[34] Clonidine-induced hypoactivity and mydriasis in mice are respectively mediated via pre- and postsynaptic alpha 2-adrenoceptors in the brain. , 1989, European journal of pharmacology.
[35] S. Iversen,et al. Proceedings: Amphetamine and apomorphine responses in the rat after lesion of mesolimbic or striatal dopamine neurones. , 1975, British journal of pharmacology.
[36] K. Berridge,et al. The incentive sensitization theory of addiction: some current issues , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[37] M. Leist,et al. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels , 2007, Brain Research.
[38] E. Bartlett,et al. Selective Sensitization to the Psychosis-Inducing Effects of Cocaine: A Possible Marker for Addiction Relapse Vulnerability? , 1997, Neuropsychopharmacology.
[39] T. Kosten,et al. Substance Abuse Vaccines , 2008, Annals of the New York Academy of Sciences.
[40] S. M. Owens,et al. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration , 2004, Pharmacology Biochemistry and Behavior.
[41] F. Carroll,et al. Effects of Murine-Derived Anti-Methamphetamine Monoclonal Antibodies on (+)-Methamphetamine Self-Administration in the Rat , 2004, Journal of Pharmacology and Experimental Therapeutics.
[42] Syed F. Ali,et al. Behavioral Consequences of Methamphetamine‐Induced Neurotoxicity in Mice: Relevance to the Psychopathology of Methamphetamine Addiction , 2002, Annals of the New York Academy of Sciences.
[43] R. A. Sewell,et al. REVIEW: Norepinephrine and stimulant addiction , 2009, Addiction biology.
[44] James Robert Brašić,et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users , 2008, Synapse.